PAVM
Price
$10.70
Change
+$0.44 (+4.29%)
Updated
Feb 5, 03:27 PM (EDT)
Capitalization
9.44M
Intraday BUY SELL Signals
SRTS
Price
$5.00
Change
+$0.12 (+2.45%)
Updated
Feb 5, 03:41 PM (EDT)
Capitalization
80.81M
Earnings call today
Intraday BUY SELL Signals
Interact to see
Advertisement

PAVM vs SRTS

Header iconPAVM vs SRTS Comparison
Open Charts PAVM vs SRTSBanner chart's image
PAVmed
Price$10.70
Change+$0.44 (+4.29%)
Volume$160
Capitalization9.44M
Sensus Healthcare
Price$5.00
Change+$0.12 (+2.45%)
Volume$197
Capitalization80.81M
PAVM vs SRTS Comparison Chart in %
PAVM
Daily Signal:
Gain/Loss:
SRTS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PAVM vs. SRTS commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAVM is a StrongBuy and SRTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 06, 2026
Stock price -- (PAVM: $10.26 vs. SRTS: $4.89)
Brand notoriety: PAVM and SRTS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: PAVM: 43% vs. SRTS: 177%
Market capitalization -- PAVM: $9.44M vs. SRTS: $80.81M
PAVM [@Medical/Nursing Services] is valued at $9.44M. SRTS’s [@Medical/Nursing Services] market capitalization is $80.81M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $188.15B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PAVM’s FA Score shows that 0 FA rating(s) are green whileSRTS’s FA Score has 1 green FA rating(s).

  • PAVM’s FA Score: 0 green, 5 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, SRTS is a better buy in the long-term than PAVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PAVM’s TA Score shows that 6 TA indicator(s) are bullish while SRTS’s TA Score has 5 bullish TA indicator(s).

  • PAVM’s TA Score: 6 bullish, 4 bearish.
  • SRTS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, PAVM is a better buy in the short-term than SRTS.

Price Growth

PAVM (@Medical/Nursing Services) experienced а +26.35% price change this week, while SRTS (@Medical/Nursing Services) price change was -4.31% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.33%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +12.28%.

Reported Earning Dates

SRTS is expected to report earnings on Feb 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (+2.33% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRTS($80.8M) has a higher market cap than PAVM($9.44M). SRTS has higher P/E ratio than PAVM: SRTS (31.50) vs PAVM (0.09). PAVM YTD gains are higher at: 54.891 vs. SRTS (22.864). PAVM has higher annual earnings (EBITDA): 1.61M vs. SRTS (-4.84M). SRTS has more cash in the bank: 24.5M vs. PAVM (3.1M). SRTS has less debt than PAVM: SRTS (534K) vs PAVM (9.28M). SRTS has higher revenues than PAVM: SRTS (35.6M) vs PAVM (29K).
PAVMSRTSPAVM / SRTS
Capitalization9.44M80.8M12%
EBITDA1.61M-4.84M-33%
Gain YTD54.89122.864240%
P/E Ratio0.0931.500%
Revenue29K35.6M0%
Total Cash3.1M24.5M13%
Total Debt9.28M534K1,738%
FUNDAMENTALS RATINGS
PAVM vs SRTS: Fundamental Ratings
PAVM
SRTS
OUTLOOK RATING
1..100
3315
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
10092
PRICE GROWTH RATING
1..100
5845
P/E GROWTH RATING
1..100
10018
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SRTS's Valuation (62) in the Medical Specialties industry is somewhat better than the same rating for PAVM (96). This means that SRTS’s stock grew somewhat faster than PAVM’s over the last 12 months.

SRTS's Profit vs Risk Rating (96) in the Medical Specialties industry is in the same range as PAVM (100). This means that SRTS’s stock grew similarly to PAVM’s over the last 12 months.

SRTS's SMR Rating (92) in the Medical Specialties industry is in the same range as PAVM (100). This means that SRTS’s stock grew similarly to PAVM’s over the last 12 months.

SRTS's Price Growth Rating (45) in the Medical Specialties industry is in the same range as PAVM (58). This means that SRTS’s stock grew similarly to PAVM’s over the last 12 months.

SRTS's P/E Growth Rating (18) in the Medical Specialties industry is significantly better than the same rating for PAVM (100). This means that SRTS’s stock grew significantly faster than PAVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PAVMSRTS
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
PAVM
Daily Signal:
Gain/Loss:
SRTS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKGSY23.391.60
+7.34%
Tokyo Gas Co., Ltd.
NRBT0.03N/A
N/A
Novus Robotics, Inc.
NXFNF4.06N/A
N/A
NEXT 15 GROUP PLC
JGSHF0.39N/A
N/A
JG Summit Holdings, Inc.
STCUF0.79-0.01
-1.53%
Star Copper Corp.

PAVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAVM has been closely correlated with MOVE. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if PAVM jumps, then MOVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
+7.21%
MOVE - PAVM
89%
Closely correlated
+4.87%
INBS - PAVM
88%
Closely correlated
-6.14%
TCMD - PAVM
73%
Closely correlated
-2.09%
PEN - PAVM
64%
Loosely correlated
-4.52%
IRMD - PAVM
58%
Loosely correlated
-4.22%
More

SRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRTS has been loosely correlated with LUNG. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SRTS jumps, then LUNG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
-5.60%
LUNG - SRTS
57%
Loosely correlated
-3.23%
PAVM - SRTS
46%
Loosely correlated
+7.21%
SENS - SRTS
43%
Loosely correlated
+1.40%
MOVE - SRTS
43%
Loosely correlated
+4.87%
AXGN - SRTS
42%
Loosely correlated
-2.81%
More